Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex

Subacute sclerosing panencephalitis (SSPE) is a late-onset and fatal viral disease caused by persistent infection of the central nervous system by measles virus (MeV). We present the case of a 10-year-old child from South Asia affected by SSPE, stabilized with a combination of intrathecal interferon...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Cras, Renan, Mazet, Roseline, Dubois-Teklali, Fanny, Sabourdy, Cécile, Chanoine, Sébastien, Lehmann, Audrey, Morin, Agathe, Leenhardt, Julien, Durand, Marjorie, Desruet, Marie-Dominique, Bedouch, Pierrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788679/
https://www.ncbi.nlm.nih.gov/pubmed/36458570
http://dx.doi.org/10.1080/22221751.2022.2148563
_version_ 1784858809653526528
author Le Cras, Renan
Mazet, Roseline
Dubois-Teklali, Fanny
Sabourdy, Cécile
Chanoine, Sébastien
Lehmann, Audrey
Morin, Agathe
Leenhardt, Julien
Durand, Marjorie
Desruet, Marie-Dominique
Bedouch, Pierrick
author_facet Le Cras, Renan
Mazet, Roseline
Dubois-Teklali, Fanny
Sabourdy, Cécile
Chanoine, Sébastien
Lehmann, Audrey
Morin, Agathe
Leenhardt, Julien
Durand, Marjorie
Desruet, Marie-Dominique
Bedouch, Pierrick
author_sort Le Cras, Renan
collection PubMed
description Subacute sclerosing panencephalitis (SSPE) is a late-onset and fatal viral disease caused by persistent infection of the central nervous system by measles virus (MeV). We present the case of a 10-year-old child from South Asia affected by SSPE, stabilized with a combination of intrathecal interferon-α2b (INF-α2b) injections and oral inosiplex and how we continued the treatment when inosiplex was commercially stopped worldwide.
format Online
Article
Text
id pubmed-9788679
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-97886792022-12-24 Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex Le Cras, Renan Mazet, Roseline Dubois-Teklali, Fanny Sabourdy, Cécile Chanoine, Sébastien Lehmann, Audrey Morin, Agathe Leenhardt, Julien Durand, Marjorie Desruet, Marie-Dominique Bedouch, Pierrick Emerg Microbes Infect Letter Subacute sclerosing panencephalitis (SSPE) is a late-onset and fatal viral disease caused by persistent infection of the central nervous system by measles virus (MeV). We present the case of a 10-year-old child from South Asia affected by SSPE, stabilized with a combination of intrathecal interferon-α2b (INF-α2b) injections and oral inosiplex and how we continued the treatment when inosiplex was commercially stopped worldwide. Taylor & Francis 2022-12-20 /pmc/articles/PMC9788679/ /pubmed/36458570 http://dx.doi.org/10.1080/22221751.2022.2148563 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter
Le Cras, Renan
Mazet, Roseline
Dubois-Teklali, Fanny
Sabourdy, Cécile
Chanoine, Sébastien
Lehmann, Audrey
Morin, Agathe
Leenhardt, Julien
Durand, Marjorie
Desruet, Marie-Dominique
Bedouch, Pierrick
Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex
title Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex
title_full Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex
title_fullStr Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex
title_full_unstemmed Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex
title_short Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex
title_sort place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? a case report of a 10-year-old child with subacute sclerosing panencephalitis (sspe) requiring inosiplex
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788679/
https://www.ncbi.nlm.nih.gov/pubmed/36458570
http://dx.doi.org/10.1080/22221751.2022.2148563
work_keys_str_mv AT lecrasrenan placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex
AT mazetroseline placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex
AT duboisteklalifanny placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex
AT sabourdycecile placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex
AT chanoinesebastien placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex
AT lehmannaudrey placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex
AT morinagathe placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex
AT leenhardtjulien placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex
AT durandmarjorie placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex
AT desruetmariedominique placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex
AT bedouchpierrick placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex

Ejemplares similares